Plain-English translation of NCT04534127 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called DaRT (Diffusing Alpha Emitters Radiation Therapy) that uses tiny radioactive seeds implanted directly into tumors on or near your skin. Unlike traditional radiation therapy that beams radiation from outside your body, these seeds deliver radiation from inside the tumor itself. Researchers want to see whether this approach can safely shrink cancers while causing fewer side effects.
Many patients with skin cancers, mouth tumors, or superficial soft tissue cancers either don't respond to standard treatments, can't tolerate surgery or radiation, or choose to refuse those options. This trial exists to see if this new treatment can offer another effective choice for people in those situations.
You likely qualify if…
You likely don't qualify if…
A doctor will insert radioactive seeds directly into your tumor during a procedure. You will then return for follow-up visits to have imaging scans and blood tests done to check how well the tumor is shrinking and whether you're experiencing any side effects. The main assessment happens 70 days after the seeds are inserted. You may be involved in the trial for several months as doctors monitor your recovery and treatment response.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
Israel
Sponsor
Alpha Tau Medical LTD.
Enrollment target
~56 participants
Started
December 2020
Primary completion
January 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Liron Dimnik
Sharett institute, Hadassah University Hospital - Ein-Kerem
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.